Understanding factors affecting racial and socioeconomic disparities in hidradenitis suppurativa
Official title: Multilevel factors influencing racial, ethnic, and socioeconomic disparities in hidradenitis suppurativa
Funded at University of California, San Francisco · NIH-10927395 · Data updated 2026-11-12
This study is looking into hidradenitis suppurativa, a painful skin condition that affects many people, especially in different racial and ethnic groups, to understand what makes it more common and how to improve treatment options for everyone dealing with it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 15, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $167,292 |
| NIH project number | 5K23AR082918-02 |
| Project ID | NIH-10927395 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with hidradenitis suppurativa, especially those from racial and ethnic minority backgrounds.
✕Less likely to help
Patients who do not have hidradenitis suppurativa or those outside the age range of 21 years and older may not benefit from this research.
What this research studies
This research investigates the chronic skin condition hidradenitis suppurativa, which causes painful abscesses and scarring, particularly among racial and ethnic minorities. The study aims to identify various factors at individual, interpersonal, and community levels that contribute to the prevalence and management of this condition. By analyzing a diverse dataset, the research will evaluate how these factors influence access to biologic therapies and overall health outcomes for patients. The goal is to develop effective interventions that can improve care for those affected by hidradenitis suppurativa.
Why it matters
Potential benefit: If successful, this research could lead to improved management strategies and healthcare access for patients suffering from hidradenitis suppurativa, particularly among underserved populations.
How similar studies have gone: Previous research has shown success in addressing health disparities in chronic conditions, indicating that this approach has potential for meaningful insights.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Chang, Aileen Yenting — University of California, San Francisco
- Study coordinator: Chang, Aileen Yenting
Related research
Other NIH-funded projects on the same topics.
-
Anti-CD38 immunotherapy for severe hidradenitis suppurativa
A new treatment using anti-CD38 therapy is being tested for people with severe hidradenitis suppurativa who have not responded to prior therapies.
-
Botulinum toxin blocks nerve signals to immune cells to treat hidradenitis suppurativa
This NIH grant tests a new approach to hidradenitis suppurativa by using botulinum toxin to interrupt nerve signals that may drive skin inflammation in patients.
-
Precision therapies for hidradenitis suppurativa using AI
A doctor-researcher team at UC San Francisco is using advanced computer methods to find personalized drug options to treat hidradenitis suppurativa.
-
Injectable Hydrogel for HS: a localized therapy to ease painful skin disease
A new baricitinib hydrogel is being developed to deliver pain relief and reduce inflammation directly in hidradenitis suppurativa (HS) lesions, potentially lowering systemic side effects.
-
Whole-genome sequencing to understand hidradenitis suppurativa in diverse groups
Researchers will study the genetic factors that contribute to hidradenitis suppurativa, especially in African American, Hispanic/Latino, and White patients, to better understand why some people are more affected.
-
Understanding the Genes Behind Hidradenitis Suppurativa in teens and young adults
A study to find genetic factors that contribute to hidradenitis suppurativa (HS), a painful skin condition that often starts in adolescence and affects many Black individuals.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.